Nuvation Bio Inc. Class A Common Stock vs Patterson-UTI Energy Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Patterson-UTI Energy Inc. Common Stock trades at $11.45 (market cap $4.28B). The key difference: Patterson-UTI Energy Inc. Common Stock is far larger — about 2.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.56% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Patterson-UTI Energy Inc. Common Stock for 0 Days on average.
| NUVB | PTEN | |
|---|---|---|
Market Cap | $1.71B | $4.28B |
Volume | 5,448,712 | 5,046,340 |
Sector | Health | Energy |
52-Week High | $9.54 | $13.15 |
52-Week Low | $3.41 | $5.37 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $5.37B |
Dividend Yield | — | 3.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.
Read more on PTEN →